MoneyWorks4Me

Concord Drugs informs about quarterly statement on investor complaints

21 Jan 2017 Evaluate

Concord Drugs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.60
Dr. Reddys Labs. 1222.80
Cipla 1326.90
Lupin 1914.75
Zydus Lifesciences 1124.50
View more..